#alz — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #alz, aggregated by home.social.
-
I'm just $85 short of my goal of raising $500 for #ALZ research. You can give @ http://act.alz.org/goto/dougwhitfield
100% of your donation goes to research.
Their score is 97%! https://www.charitynavigator.org/ein/133039601
International Committee for the Red Cross is just 86%: https://www.charitynavigator.org/ein/986001029
The New Orleans Friends of Music is 83%: https://www.charitynavigator.org/ein/726021704
This is not to shame anyone, but to give some context to the Alzheimer's Association being good!
If everyone that saw this gave $5 I would be there in no time!
-
I'm just $85 short of my goal of raising $500 for #ALZ research. You can give @ http://act.alz.org/goto/dougwhitfield
100% of your donation goes to research.
Their score is 97%! https://www.charitynavigator.org/ein/133039601
International Committee for the Red Cross is just 86%: https://www.charitynavigator.org/ein/986001029
The New Orleans Friends of Music is 83%: https://www.charitynavigator.org/ein/726021704
This is not to shame anyone, but to give some context to the Alzheimer's Association being good!
If everyone that saw this gave $5 I would be there in no time!
-
AlzForumin kevään konferenssi-koosteet:
AD/PD 2025:stä Wienissä, https://www.alzforum.org/news/conference-coverage/adpdtm-2025-advances-science-therapy
Tau Globalista Lontoossa, https://www.alzforum.org/news/conference-coverage/tau-global-conference#alz #alzheimer #konferenssi #conference #news #tau #tauopathy #amyloidosis #muistisairaus #lääketiede #neuro #medicine #tutkimus #research #clinical #parkinsons #ad #pd
-
The #Trump administration wants to address #chronicdisease but just cut funding to a 30-year-long diabetes study.
It found non-pharmaceutical ways to cut the likelihood of getting diabetes by 58% and now is studying #Alzheimer's + #diabetes—all priorities for RFK Jr.
Why pull the funding now? Elaine Chen
@STAT has more:#maha #health #healthcare #medicine #research #Healthpolicy #RFK #ALZ
-
“BenfoTeam is [a] version of vitamin B1, known as benfotiamine. Researchers said early tests show it could possibly slow down or even reverse Alzheimer’s.
“This trial is for people 50-89 with mild memory concerns or mild Alzheimer’s disease. People can’t be in a long-term care facility and must be willing to participate in the full 18-month program.”
https://www.actionnews5.com/2024/09/04/clinical-trial-groundbreaking-alzheimers-disease-drug-begins-middle-tennessee/
#Alzheimers #alz #dementia -
A possible clue in the hunt for what exactly causes Alzheimer's: It looks like Alzheimer's might be able to be transmitted.
Based on VERY rare cases of people who had, as children, received growth hormone taken from the brains of human cadavers and later developed early-onset Alzheimer's, it looks like ALZ might be related to prion diseases like Creutzfeldt-Jakob
#alz #AD #alzheimers #prion #dementia #health #medicine #research #MedMastodon
-
An AlzForum overview of the current status of Alzheimer research and treatment, https://www.alzforum.org/news/community-news/2023-bumper-year-treatment-and-science-alzheimers
#Alz #Alzheimer #alzheimers #research #treatment #current #news #dementia
-
[Share] azure-monitor-baseline-alerts (amba)- Alerts for Azure Landing Zone
When deploying Azure resources, it is crucial to configure alerts to ensure the health, performance, and security of your resources.
https://azure.github.io/azure-monitor-baseline-alerts/welcome/
-
And don't miss Megan on the latest episode of the Readout Loud podcast: https://www.statnews.com/2023/07/13/wegovy-brain-alzheimers-data-leqembi/
-
First missive from the #biotech desk:
After leading the company a presumed blockbuster #alzheimers drug, Eisai's head of #ALZ and US operations, Ivan Cheung, 46, to retire.
His brother-in-law and son of Eisai founder, Keisuke Naito, 34, will replace him on ALZ.
https://www.statnews.com/2023/07/11/eisai-executive-who-helped-lead-development-of-alzheimers-drug-to-retire/ -
BREAKING: #FDA gives full approval to first #Alzheimer’s therapy shown to clearly slow cognitive decline — a milestone in treatment, even if the benefits are modest.
via @STAT's @adamfeuerstein and Damian Garde
https://www.statnews.com/2023/07/06/leqembi-alzheimers-fda-approval-eisai-biogen/
#ALZ #health #healthcare #CMS #medicine #neuroscience #biotech
-
Women who worked for pay in early adulthood and midlife experienced slower rates of later-life memory decline, regardless of whether they married or had children.
https://www.ncbi.nlm.nih.gov/pubmed/33148811
#HRSData #Cognition #Health #Aging #WorkingWomen #Alz #NICHDimpact
-
Breaking: #FDA approves Eisai-Biogen #Alzheimer's #ALZ drug #Leqembi, also known as #lecanemab: https://www.statnews.com/2023/01/06/fda-approves-alzheimers-drug-leqembi-eisai/
-
Older people with high income and education levels can expect to live a larger portion of their later years without dementia than lower education and lower income people. Time with dementia is compressed for older people with higher income and education level.
https://www.ncbi.nlm.nih.gov/pubmed/34584932
#Alz #Dementia #Cognition #CognitiveHealth #Aging #SES #NICHDImpact @cognition